Cavers Greg Insider Trades & Stock Holdings

Chief Financial Officer · Cybin D/B/A Helus Pharma · Latest filing Sep 29, 2026

Cavers Greg, Chief Financial Officer at Cybin D/B/A Helus Pharma has 1 Form 4 trade on file since Sep 29, 2026. Open-market activity: 1 purchase ($38.73K) and 0 sales ($0), net +$38.73K. Latest filing: acquired 3K shares of $HELP on Sep 29, 2026 at $12.91.

Trades on file

1

Open-market bought

$38.73K

Open-market sold

$0

Net open-market

+$38.73K

Latest filing

Sep 29, 2026

All insider trades by Cavers Greg

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 29, 2026	$HELP	Buy (Open-market buy)	3K	$12.91	$38.73K			-15.3%			Chief Financial Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Cavers Greg traded

• $HELP

Frequently asked questions

Has Cavers Greg been buying or selling stock?

Cavers Greg has 1 open-market purchase and 0 open-market sales on file, net +$38.73K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Cavers Greg's latest insider trade?

acquired 3K shares of $HELP on Sep 29, 2026 at $12.91.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.